MedPath
HSA Approval

STOCRIN® 200mg TABLET

SIN13509P

STOCRIN® 200mg TABLET

STOCRIN® 200mg TABLET

July 31, 2008

MSD PHARMA (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMSD PHARMA (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J05AG03

efavirenz

Manufacturer Information

MSD PHARMA (SINGAPORE) PTE. LTD.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Active Ingredients

Efavirenz

200.0 mg

Efavirenz

Documents

Package Inserts

STOCRIN_PI_Approved.pdf

Approved: July 27, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STOCRIN® 200mg TABLET - HSA Approval | MedPath